Search Press releases

Press releases teaser image
30 Jul 2026

UCB Delivers Strong Results, Raises 2026 Guidance and Positions for Next Growth Phase

Read More
Press releases teaser image
8 Jul 2026

UCB presents latest data from its targeted generalized myasthenia gravis treatment portfolio at International Congress on Neuromuscular Diseases 2026

Read More
Press releases teaser image
17 Jun 2026

UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI[®]▼ (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)

Read More
Press releases teaser image
17 Jun 2026

UCB completes acquisition of Candid Therapeutics, strengthening next generation immunology pipeline

Read More
Press releases teaser image
5 Jun 2026

New EULAR 2026 data show CIMZIA[®] (certolizumab pegol) delivered consistent effect in rheumatoid arthritis, regardless of rheumatoid factor (RF) levels

Read More
Press releases teaser image
4 Jun 2026

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe